Yuanzhou He

818 total citations
31 papers, 608 citations indexed

About

Yuanzhou He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yuanzhou He has authored 31 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Yuanzhou He's work include Pulmonary Hypertension Research and Treatments (10 papers), Cancer-related molecular mechanisms research (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Yuanzhou He is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Cancer-related molecular mechanisms research (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Yuanzhou He collaborates with scholars based in China. Yuanzhou He's co-authors include Xiansheng Liu, Xiaochen Li, Yongjian Xu, Min Xie, Xiaopei Cao, Xiaoyu Fang, Mengzhe Zhang, Yongjian Xu, Jing Shi and Jin Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and Frontiers in Immunology.

In The Last Decade

Yuanzhou He

29 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanzhou He China 15 300 195 164 85 61 31 608
Zeqi Zheng China 17 381 1.3× 102 0.5× 158 1.0× 89 1.0× 53 0.9× 48 786
Wunai Zhang China 10 348 1.2× 132 0.7× 119 0.7× 70 0.8× 47 0.8× 15 611
Xuan Fang China 15 455 1.5× 146 0.7× 237 1.4× 101 1.2× 44 0.7× 42 781
Bowen Li China 14 226 0.8× 140 0.7× 119 0.7× 67 0.8× 32 0.5× 46 556
Ying Xiao China 18 394 1.3× 83 0.4× 150 0.9× 102 1.2× 63 1.0× 41 746
Taijyu Satoh Japan 16 272 0.9× 273 1.4× 97 0.6× 51 0.6× 43 0.7× 37 723
Xiangxiang Wei China 11 497 1.7× 92 0.5× 117 0.7× 70 0.8× 61 1.0× 17 711
Juhyung Woo United States 11 270 0.9× 99 0.5× 113 0.7× 129 1.5× 68 1.1× 26 507
Wenqian Zhou China 12 370 1.2× 262 1.3× 208 1.3× 48 0.6× 30 0.5× 22 712
Yuqiong Chen China 12 390 1.3× 121 0.6× 165 1.0× 86 1.0× 38 0.6× 33 595

Countries citing papers authored by Yuanzhou He

Since Specialization
Citations

This map shows the geographic impact of Yuanzhou He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanzhou He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanzhou He more than expected).

Fields of papers citing papers by Yuanzhou He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanzhou He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanzhou He. The network helps show where Yuanzhou He may publish in the future.

Co-authorship network of co-authors of Yuanzhou He

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanzhou He. A scholar is included among the top collaborators of Yuanzhou He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanzhou He. Yuanzhou He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liao, Zhipeng & Yuanzhou He. (2025). Exploring the interplay between mitochondria and endoplasmic reticulum in pulmonary arterial hypertension. Frontiers in Cardiovascular Medicine. 12. 1623775–1623775.
3.
Huang, Yuchen, et al.. (2024). Identification of novel biomarkers related to neutrophilic inflammation in COPD. Frontiers in Immunology. 15. 1410158–1410158. 9 indexed citations
4.
Li, Xiaochen, et al.. (2023). The associations between asthma and common comorbidities: a comprehensive Mendelian randomization study. Frontiers in Medicine. 10. 1251827–1251827. 5 indexed citations
5.
Zhang, Mengzhe, et al.. (2022). Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects. Frontiers in Immunology. 13. 824188–824188. 94 indexed citations
6.
Fang, Xiaoyu, Min Xie, Xiansheng Liu, & Yuanzhou He. (2022). REDD1 gene knockout alleviates vascular smooth muscle cell remodeling in pulmonary hypertension.. PubMed. 14(3). 1578–1591. 2 indexed citations
7.
Cao, Xiaopei, Xiaoyu Fang, Mingzhou Guo, et al.. (2021). TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension. Respiratory Research. 22(1). 312–312. 19 indexed citations
8.
He, Yuanzhou, et al.. (2021). Proteomic analysis reveals that Xbp1s promotes hypoxic pulmonary hypertension through the p‐JNK MAPK pathway. Journal of Cellular Physiology. 237(3). 1948–1963. 9 indexed citations
9.
Fang, Xiaoyu, Min Xie, Xiansheng Liu, & Yuanzhou He. (2021). CENPE contributes to pulmonary vascular remodeling in pulmonary hypertension. Biochemical and Biophysical Research Communications. 557. 40–47. 3 indexed citations
10.
He, Xiaodan, et al.. (2021). Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis. Clinical & Translational Oncology. 24(1). 34–47. 22 indexed citations
11.
He, Yuanzhou, Xiaoyu Fang, Jing Shi, et al.. (2020). Apigenin attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1α–KV1.5 channel pathway. Chemico-Biological Interactions. 317. 108942–108942. 44 indexed citations
12.
Cao, Xiaopei, Yuanzhou He, Xiaochen Li, Yongjian Xu, & Xiansheng Liu. (2019). The IRE1α-XBP1 pathway function in hypoxia-induced pulmonary vascular remodeling, is upregulated by quercetin, inhibits apoptosis and partially reverses the effect of quercetin in PASMCs.. Europe PMC (PubMed Central). 11(2). 641–654. 41 indexed citations
13.
He, Yuanzhou, Nian Sun, Wensheng Zhang, et al.. (2019). Ewing sarcoma/primitive neuro-ectodermal tumor of the urogenital system in children: a retrospective observational case series. Journal of Pediatric Urology. 15(5). 556.e1–556.e7. 5 indexed citations
14.
He, Yuanzhou, et al.. (2019). Melatonin regulates mitochondrial function and biogenesis during rat dental papilla cell differentiation.. PubMed. 23(13). 5967–5979. 18 indexed citations
15.
He, Yuanzhou, Xiaohong Wu, Yan Cao, et al.. (2016). Daidzein exerts anti-tumor activity against bladder cancer cells via inhibition of FGFR3 pathway. Neoplasma. 63(4). 523–531. 34 indexed citations
16.
Shi, Jing, Xian-Ying Zhu, Min Xie, et al.. (2016). MBL2 polymorphisms and the risk of asthma. Annals of Allergy Asthma & Immunology. 117(4). 417–422.e1. 1 indexed citations
17.
He, Yuanzhou, Xiaopei Cao, Xiansheng Liu, et al.. (2015). Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway. Experimental Cell Research. 339(1). 122–134. 38 indexed citations
18.
Li, Xiaochen, Xiansheng Liu, Yongjian Xu, et al.. (2014). Expression profile of apoptotic and proliferative proteins in hypoxic HUVEC treated with statins. International Journal of Oncology. 46(2). 677–684. 10 indexed citations
19.
He, Yuanzhou, Xiang-Qin Xu, Huilong Chen, et al.. (2013). The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: A meta-analysis. Gene. 523(2). 199–204. 6 indexed citations
20.
Zhang, Xuemin & Yuanzhou He. (2007). Influence of educational attainment on consumption. Frontiers of Education in China. 2(2). 259–272. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026